Author

Kowthar Y. Salim

Observed names: KOWTHAR Y. SALIM, Kowthar Y Salim, Salim, Kowthar Yislam

Institution: Cotinga Pharmaceuticals (Canada)

Observed institutions: University of Toronto, Cotinga Pharmaceuticals (Canada)

OpenAlex ID: A5108516431

COTI-2, a novel small molecule that is active against multiple human cancer cell linesin vitroandin vivo

2016 · Kowthar Y. Salim, Saman Maleki Vareki, et al. · Oncotarget · 155

Descriptions and Phylogenetic Systematics of Myxobolus spp. from Cyprinids in Algonquin Park, Ontario

2000 · KOWTHAR Y. SALIM, SHERWIN S. DESSER · Journal of Eukaryotic Microbiology · 59

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines

2018 · Saman Maleki Vareki, Kowthar Y. Salim, et al. · PLoS ONE · 46

Identification of Group A Streptococcus Antigenic Determinants Upregulated In Vivo

2005 · Kowthar Y. Salim, Dennis G. Cvitkovitch, et al. · Infection and Immunity · 34

Abstract CT033: Safety and early efficacy signals for COTI-2, an orally available small molecule targeting p53, in a phase I trial of recurrent gynecologic cancer

2018 · Shannon N. Westin, Wilberto Nieves-Neira, et al. · Cancer Research · 19

Regulation ofsagA, siaAandscpCby SilCR, a putative signaling peptide ofStreptococcus pyogenes

2008 · Kowthar Y. Salim, Joyce C. de Azavedo, et al. · FEMS Microbiology Letters · 14

Role for sagA and siaA in Quorum Sensing and Iron Regulation in Streptococcus pyogenes

2007 · Kowthar Y. Salim, Joyce C. de Azavedo, et al. · Infection and Immunity · 10

Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo

2017 · Kowthar Y. Salim, Saman Maleki Vareki, et al. · Oncotarget · 5

COTI-2, a potent orally available small molecule targeting mutant p53, with promising efficacy as monotherapy and combination treatment in preclinical tumor models.

2018 · Richard T Ho, Kowthar Y Salim, et al. · Journal of Clinical Oncology · 4

Streptolysin S: one of the most potent and elusive of all bacterial toxins

2006 · Joyce C.S. de Azavedo, Kowthar Y. Salim, et al. · Elsevier eBooks · 2

Abstract A25: COTI-2, a novel small molecule that is effective against multiple human cancer cell lines in vitro and in vivo

2017 · Kowthar Y. Salim, Saman Maleki Vareki, et al. · Clinical Cancer Research · 1

In vivo induced antigenic determinants of group A Streptococcus

2007 · Salim, Kowthar Yislam · TSpace (University of Toronto)

2006 · K. Ravi Acharya, Martin A. Acquadro, et al. · Elsevier eBooks

Works count: 14

Citation count: 349

H-index: 7

I10-index: 7